MR spectroscopy of the human prostate using surface coil at 3 T: Metabolite ratios, age-dependent effects, and diagnostic possibilities

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 6, 2011, Pages 1277-1284

  Weis, Jan ^a   Jorulf, Hkan ^a   Bergman, Antonina ^a   Ortiz Nieto, Francisco ^a   Häggman, Michael ^a   Ahlström, Hkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

3 Tesla; LCModel; prostate cancer; single voxel spectroscopy; spectroscopic imaging; surface coil

Indexed keywords

CITRIC ACID;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; GROUPS BY AGE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL RESOLUTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY ANALYSIS; SINGLE VOXEL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TWO DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; AGE FACTORS; AGED; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 81755177859     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22746     Document Type: Article

References (28)

1. 3) spatial resolution. Radiology 1996; 198: 795-805.
2. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 1999; 213: 473-480.
3. 1H MR spectroscopic imaging findings - initial observations. Radiology 2004; 231: 717-724.
4. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005; 234: 804-814.
5. Mueller-Lisse UG, Scherr MK,. Proton MR spectroscopy of the prostate. Eur J Radiol 2007; 63: 351-360.
6. Scheenen TWJ, Klomp DWJ, Röll SA, et al. Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate. Magn Reson Med 2004; 52: 80-88.
7. Pohmann R, von Kienlin M,. Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn Reson Med 2001; 45: 817-826.
8. Scheenen TWJ, Heijmink SWTPJ, Roell SA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology 2007; 245: 507-516.
9. Heijmink SWTPJ, Scheenen TWJ, Fütterer JJ, et al. Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy. Invest Radiol 2007; 42: 420-427.
10. 1H-MR spectroscopic imaging of the human prostate at 3 T. Magn Reson Med 2005; 53: 1268-1274.
11. Verma S, Rajesh A, Fütterer JJ, et al. Prostate MRI and 3D MR spectroscopy: how we do it. Am J Radiol 2010; 194: 1414-1426.
12. 1H- spectroscopic imaging of the prostate. Invest Radiol 2004; 39: 671-680.
13. Chen AP, Cunningham CH, Kurhanewicz J, et al. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. Magn Reson Imaging 2006; 24: 825-832.
14. Kaji Y, Wada A, Imaoka I, et al. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil. J Magn Reson Imaging 2002; 16: 697-706.
15. Kaji Y, Kuroda K, Maeda T, et al. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy human volunteer study. J Magn Reson Imaging 2007; 25: 517-526.
16. 1H-MRSI in vivo at 3 Tesla. Magn Reson Med 2011; 65: 914-919.
17. Kim H-W, Buckley DL, Peterson DM, et al. In vivo prostate magnetic resonance imaging and magnetic resonance spectroscopy at 3 Tesla using a transceive pelvic phased array coil. Invest Radiol 2003; 38: 443-451.
18. Rosen Y, Bloch BN, Lenkinski RE, et al. 3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension. Magn Reson Med 2007; 57: 898-904.
19. Provencher SW,. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
20. Star-Lack J, Nelson SJ, Kurhanewicz J, et al. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997; 38: 311-321.
21. Freeman R,. A handbook of nuclear magnetic resonance. Essex, UK: Longman; 1988.
22. 1H MRS spectra from brain tumours. NMR Biomed 1998; 11: 177-191.
23. 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification. NMR Biomed 2007; 20: 763-770.
24. 1H MR spectra. J Magn Reson 2004; 170: 164-175.
25. Weis J, Bergman A, Ortiz-Nieto F, et al. Spectroscopy of the human prostate at 3 Tesla using surface coil: age-related changes. In: Proc 18th Annual Meeting ISMRM, Stockholm; 2010: 323.
26. Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: zonal and age-related differences. Magn Reson Med 1996; 36: 352-358.
27. Langer DL, van der Kwast TH, Evans AJ, et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast enhanced MRI. J Magn Reson Imaging 2009; 30: 327-334.
28. 1H MR spectroscopic imaging - correlation with pathologic findings. Radiology 2008; 246: 480-488.